Searched for
ORAL ANTIVIRAL DRUG
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in Congo
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Hetero's oral drug gets WHO PrequalificationIt is the first prequalification for a generic version of Pfizer's Covid-19 oral antiviral drug paxlovid, the company said. The WHO made a ...27 Dec, 2022, 12.32 AM IST
- New antiviral drug combo highly effective against COVID-19: Study"Identifying combinations of antivirals is really important, not only because doing so may increase the drugs' potency against the coronavi...09 Feb, 2022, 12.13 PM IST
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...07 Jan, 2022, 04.06 PM IST
- Lupin launches Molnulup for COVID-19 treatmentMolnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 pati...07 Jan, 2022, 12.31 PM IST
- Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...31 Dec, 2021, 06.54 AM IST
- US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...30 Dec, 2021, 01.24 PM IST
- Cipla to launch Molnupiravir under Cipmolnu brand name for COVID-19 treatment"This launch is yet another step in our endeavour to enable access to all treatments in COVID care. We continue to be guided by the power o...28 Dec, 2021, 05.00 PM IST
- Pfizer Inc signs $5.3 billion COVID-19 pill deal with US govtThe company earlier this month said the drug cut by 89% the chance of hospitalization or death for adults at risk of severe disease. The tr...18 Nov, 2021, 06.19 PM IST
- Indian pharma eyes affordable antiviral medicines to treat Covid-19The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...17 Nov, 2021, 06.12 PM IST
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...16 Nov, 2021, 07.33 PM IST
- India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...12 Oct, 2021, 01.40 PM IST
- Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...22 May, 2021, 08.15 PM IST
- Dr Reddy’s warns public on spurious versions of 2DG, its anti-Covid drug, in the market“2DG is an oral antiviral drug that can be administered only upon prescription to hospitalized moderate to severe Covid-19 patients as adju...20 May, 2021, 03.44 PM IST
- Jubilant Pharmova arm completes studies using novel oral formulation of RemdesivirJubilant Pharma has successfully completed "safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India ...19 Apr, 2021, 08.03 PM IST
- Pfizer begins early-stage study of oral drug to combat coronavirusThe drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...23 Mar, 2021, 10.41 PM IST
- Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drugThe Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigat...02 Dec, 2020, 01.48 PM IST
- Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...06 Aug, 2020, 04.01 PM IST
Load More
